CompletedNot Applicable

Evaluation of the Evolution of Pregnancies in the First Trimester Following MAR Management During a COVD-19 Pandemic Period

France700 participantsStarted 2020-08-01

Plain-language summary

Because of the physiological changes inherent in pregnancy, pregnant women with lower respiratory tract infections often have more worrisome outcomes compared to non-pregnant individuals, including a higher rate of hospital and intensive care unit admissions.

Who can participate

Age range18 Years – 43 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient included in a Medically Assisted Procreation (MAR) protocol aged between 18 and 43 years of age * Patient who has already signed a consent to management Exclusion Criteria: * Patient who expressed opposition to participating in the study

What they're measuring

Study of the evolution of pregnancies in the first trimester following MAR management during a COVD-19 pandemic period

Timeframe: 12th week of Amenorrhea

Trial details

NCT IDNCT04415359

SponsorUniversity Hospital, Strasbourg, France

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-10-31

View on ClinicalTrials.gov More Covid-19 trials